Since today's best medical practice is not always tomorrow, Wolf Administration has introduced procedures for changes in the existing list…
Since today’s best medical practice is not always tomorrow, Wolf Administration has introduced procedures for changes in the existing list of 21 diseases or medical conditions, and their patients can turn to forms of medical marijuana.
The new process released Friday by the State Department of Health, would touch such requests to the state’s medical marijuana advisory board for first review.
Members of the public or physician making a request form are now published on the Health website – would be required to provide documentation supporting the use of medical marijuana as a treatment for the proposed state, as well as supporting a finding that the benefits of the new therapies should outweigh any health risks.
The applications will be reviewed by a subcommittee of advisory committee and presented to the Board, meeting quarterly, for voting on or by recommendation. Approved applications would then go to the State Health Secretary, who would certify changes to the list.
State Secretary for Health Dr Rachel Levine said setting up such a process to change the list of approved conditions is meaningful.
“As medical literature surrounding the use of medical marijuana expands, we want to make sure our list of qualified conditions meets Pennsylvania’s needs,” said Levine in a statement Friday on the new procedures.
“This process will allow them with serious medical conditions that apply to their condition being part of the list of Qualified Terms, supported by doctors and documentation supporting their application.”
The new process is a The emergence of a statutory two-year review of programs of the advisory board, which the secretary was entitled to issue regulations as the custom program.
Such a change that allows the sale and use of dry leaf forms of marijuana as part of the medical program was conducted this summer.
Levine already broadened the list of initial conditions after receiving the two-year review, adding conditions as substitution therapies, or specifying medical marijuana application.
The establishment of the process for an ongoing review of the list of accepted terms is also included in the Board’s April report.
So far, the health department has said that more than 64,000 patients across the country actively participate in the medical marijuana program launched in February and work through 945 doctors who have been approved as practitioners.
The current list of approved medical marijuana conditions in Pennsylvania includes: chronic pain, amyotrophic lateral sclerosis, autism, cancer, Crohn’s disease, central nervous system nervous system disorders, spastic movement disorders, epilepsy, glaucoma, HIV / AIDS, Huntington’s disease inflammatory bowel disease, uncontrolled seizures, multiple sclerosis, neurodegenerative diseases, neuropathies, opioid disorder, Parkinson’s disease, post-traumatic stress disorder, sickle cell anemia and terminal disease.